Document Detail


A pilot trial of integrated behavioral activation and sexual risk reduction counseling for HIV-uninfected men who have sex with men abusing crystal methamphetamine.
MedLine Citation:
PMID:  23030605     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Crystal methamphetamine use is a major driver behind high-risk sexual behavior among men who have sex with men (MSM). Prior work suggests a cycle of continued crystal methamphetamine use and high-risk sex due to loss of the ability to enjoy other activities, which appears to be a side effect of this drug. Behavioral activation (BA) is a treatment for depression that involves learning to reengage in life's activities. We evaluated a novel intervention for crystal methamphetamine abuse and high-risk sex in MSM, incorporating 10 sessions of BA with integrated HIV risk reduction counseling (RR). Forty-four subjects were screened, of whom 21 met initial entry criteria. A total of 19 participants enrolled; 16 completed an open-phase study of the intervention. Behavioral assessments were conducted at baseline, 3 months postbaseline, and 6 months postbaseline. Linear mixed effects regression models were fit to assess change over time. Mean unprotected anal intercourse (UAI) episodes decreased significantly from baseline to acute postintervention (β=-4.86; 95% confidence interval [CI]=-7.48, -2.24; p=0.0015) and from baseline to 6 months postbaseline (β=-5.07; 95% CI=-7.85, -2.29; p=0.0017; test of fixed effects χ(2)=16.59; df=2,13; p=0.0002). On average, there was a significant decrease over time in the number of crystal methamphetamine episodes in the past 3 months (χ(2)=22.43; df=2,15; p<0.0001), and the number of days of crystal methamphetamine use in the past 30 days (χ(2)=9.21; df=2,15; p=0.010). Statistically significant reductions in depressive symptoms and poly-substance use were also maintained. Adding behavioral activation to risk reduction counseling for MSM with problematic crystal methamphetamine use may augment the potency of a risk reduction intervention for this population. Due to the small sample size and time intensive intervention, future testing in a randomized design is necessary to determine efficacy, with subsequent effectiveness testing.
Authors:
Matthew J Mimiaga; Sari L Reisner; David W Pantalone; Conall O'Cleirigh; Kenneth H Mayer; Steven A Safren
Related Documents :
24876745 - Risk calculators for hepatocellular carcinoma in patients affected with chronic hepatit...
24020605 - Rural women's strategic responses to intimate partner violence.
3202455 - The effects of kaolin on the lung.
24296735 - Use and effectiveness of lapse prevention strategies among pregnant smokers.
1439515 - Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men wit...
17173715 - Modifiable risk factors for developing diabetes among women with previous gestational d...
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, N.I.H., Extramural     Date:  2012-10-03
Journal Detail:
Title:  AIDS patient care and STDs     Volume:  26     ISSN:  1557-7449     ISO Abbreviation:  AIDS Patient Care STDS     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-08     Completed Date:  2013-04-02     Revised Date:  2013-11-05    
Medline Journal Info:
Nlm Unique ID:  9607225     Medline TA:  AIDS Patient Care STDS     Country:  United States    
Other Details:
Languages:  eng     Pagination:  681-93     Citation Subset:  IM; X    
Affiliation:
Department of Psychiatry, Harvard Medical School/Massachusetts General Hospital, Boston, Massachusetts 02114, USA. mmimiaga@hsph.harvard.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Central Nervous System Stimulants*
Confidence Intervals
Depression / epidemiology,  prevention & control*,  psychology
Drug Users*
HIV Infections / epidemiology,  prevention & control*,  psychology
Health Knowledge, Attitudes, Practice
Homosexuality, Male* / psychology
Humans
Male
Methamphetamine*
Middle Aged
Pilot Projects
Risk Reduction Behavior*
Safe Sex
Sex Counseling*
Sexual Behavior
Sexual Partners* / psychology
Grant Support
ID/Acronym/Agency:
K24 MH094214/MH/NIMH NIH HHS; R03DA023393/DA/NIDA NIH HHS; R34 DA031028/DA/NIDA NIH HHS
Chemical
Reg. No./Substance:
0/Central Nervous System Stimulants; 537-46-2/Methamphetamine
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fabrication of Large Domain Crack-Free Colloidal Crystal Heterostructures with Superposition Bandgap...
Next Document:  Why are current efforts to eliminate female circumcision in Ethiopia misplaced?